Skip to main content
. 2020 Aug 1;40(12):3469–3479. doi: 10.1007/s10792-020-01533-y

Table 4.

Meibomian gland loss of the lower eyelid in OMGD and HMGD subjects

Degree OMGD HMGD
0 0% (0/25) 0% (0/25)
1 48% (12/25) 40% (10/25)
2 44% (11/25) 52% (13/25)
3 4% (1/25) 8% (2/25)